ストックスクリーナーアプリを入手
7.68
0.90%
-0.07
前日終値:
$7.75
開ける：
$7.71
24時間の取引高:
152.87K
Relative Volume:
0.84
時価総額：
$164.18M
収益：
$66.59M
当期純損益:
$-104.93M
株価収益率:
-1.5515
EPS:
-4.95
ネットキャッシュフロー:
$-96.48M
1週間 パフォーマンス:
+0.52%
1か月 パフォーマンス:
-11.21%
6か月 パフォーマンス:
+31.06%
1年 パフォーマンス:
-26.65%
1日の値動き範囲:
$7.52
$7.95
1週間の範囲:
$7.165
$8.01
52週間の値動き範囲:
$4.09
$13.37
Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile
名前
Enanta Pharmaceuticals Inc
セクター
電話
617 607 0800
住所
4 KINGSBURY AVENUE, WATERTOWN, MA
ENTA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENTA
Enanta Pharmaceuticals Inc
|
7.68 | 165.68M | 66.59M | -104.93M | -96.48M | -4.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.22 | 97.91B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.28 | 58.93B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.42 | 58.88B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
716.78 | 43.52B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
325.31 | 36.11B | 3.81B | -644.79M | -669.77M | -6.24 |
Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-28 | 再開されました | H.C. Wainwright | Buy |
| 2023-08-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-08-08 | ダウングレード | Jefferies | Buy → Hold |
| 2022-12-09 | 開始されました | H.C. Wainwright | Buy |
| 2022-07-06 | アップグレード | Evercore ISI | In-line → Outperform |
| 2022-06-01 | アップグレード | Evercore ISI | Underperform → In-line |
| 2021-10-07 | 開始されました | Jefferies | Buy |
| 2021-09-09 | 開始されました | SVB Leerink | Mkt Perform |
| 2021-01-29 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-11-24 | 開始されました | Evercore ISI | Underperform |
| 2020-08-28 | 再開されました | ROTH Capital | Buy |
| 2020-08-26 | 開始されました | Piper Sandler | Overweight |
| 2020-07-27 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-03-17 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-11-22 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2019-05-24 | 開始されました | Wolfe Research | Outperform |
| 2019-04-23 | アップグレード | Berenberg | Hold → Buy |
| 2018-12-13 | 開始されました | Berenberg | Hold |
| 2018-06-06 | 開始されました | ROTH Capital | Buy |
| 2018-02-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2018-01-02 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2017-11-21 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-09-15 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-07-11 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-04-28 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2016-02-09 | 繰り返されました | Barclays | Underweight |
| 2015-10-23 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2015-10-23 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
すべてを表示
Enanta Pharmaceuticals Inc (ENTA) 最新ニュース
Is Enanta Pharmaceuticals Inc. (9EP) stock bottoming after sell offSwing Trade & Daily Stock Momentum Reports - newser.com
Will Enanta Pharmaceuticals Inc. stock benefit from AI adoptionDollar Strength & Consistent Growth Equity Picks - newser.com
Why Enanta Pharmaceuticals Inc. (9EP) stock gets analyst attentionEarnings Overview Summary & AI Powered Market Entry Ideas - newser.com
How to recover losses in Enanta Pharmaceuticals Inc. stockSell Signal & Safe Entry Trade Reports - newser.com
Backtesting results for Enanta Pharmaceuticals Inc. trading strategies2025 Top Decliners & Community Verified Trade Alerts - newser.com
What Fibonacci levels say about Enanta Pharmaceuticals Inc. rebound2025 Volatility Report & Weekly High Conviction Trade Ideas - newser.com
What’s next for Enanta Pharmaceuticals Inc. stock price2025 Earnings Impact & Technical Pattern Recognition Alerts - newser.com
Chart based analysis of Enanta Pharmaceuticals Inc. trendsEarnings Beat & High Accuracy Swing Entry Alerts - newser.com
Real time alert setup for Enanta Pharmaceuticals Inc. performanceJuly 2025 Opening Moves & Technical Pattern Alert System - newser.com
What’s the recovery path for long term holders of Enanta Pharmaceuticals Inc.2025 Market Trends & Safe Swing Trade Setups - newser.com
Is Enanta Pharmaceuticals Inc. stock entering bullish territoryWall Street Watch & Growth-Oriented Investment Plans - newser.com
Growth Recap: Whats the outlook for Enanta Pharmaceuticals Incs sectorPortfolio Gains Report & Weekly Hot Stock Watchlists - خودرو بانک
Institutional scanner results for Enanta Pharmaceuticals Inc.July 2025 Retail & Short-Term Trading Alerts - newser.com
AI Stocks: What are Enanta Pharmaceuticals Incs technical support levelsWeekly Volume Report & AI Powered Market Trend Analysis - خودرو بانک
Quantitative breakdown of Enanta Pharmaceuticals Inc. recent move2025 Winners & Losers & Comprehensive Market Scan Insights - newser.com
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Evercore ISI Lowers Enanta Pharmaceuticals (NASDAQ:ENTA) Price Target to $12.00 - MarketBeat
Earnings visualization tools for Enanta Pharmaceuticals Inc.2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
Signal strength of Enanta Pharmaceuticals Inc. stock in tech scannersJuly 2025 Decliners & High Return Stock Watch Alerts - newser.com
Valuation Update: Can Enanta Pharmaceuticals Inc reach all time highs this yearJuly 2025 Institutional & Long-Term Safe Return Strategies - خودرو بانک
Best data tools to analyze Enanta Pharmaceuticals Inc. stockQuarterly Market Summary & Free High Accuracy Swing Entry Alerts - newser.com
Is Enanta Pharmaceuticals Inc. showing signs of accumulationTrade Entry Report & Safe Capital Growth Plans - newser.com
How moving averages guide Enanta Pharmaceuticals Inc. tradingMarket Activity Recap & Risk Managed Trade Strategies - newser.com
Aug Drivers: Can Enanta Pharmaceuticals Inc be recession proof2025 Market Trends & Weekly Market Pulse Alerts - خودرو بانک
Is now a turning point for Enanta Pharmaceuticals Inc.Market Growth Report & Entry Point Confirmation Alerts - newser.com
Enanta Pharmaceuticals Inc. stock retracement – recovery analysisQuarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Risk Hedge: Whats the outlook for Enanta Pharmaceuticals Incs sector2025 Fundamental Recap & Weekly Market Pulse Updates - خودرو بانک
Analyzing Enanta Pharmaceuticals Inc. with risk reward ratio chartsWeekly Loss Report & Low Drawdown Investment Ideas - newser.com
How to read the order book for Enanta Pharmaceuticals Inc.Quarterly Portfolio Summary & Growth-Oriented Investment Plans - newser.com
Can Enanta Pharmaceuticals Inc sustain earnings growthWeekly Volume Report & Reliable Entry Point Trade Alerts - خودرو بانک
Primary Biliary Cholangitis Market Expected to Gain Momentum Through 2034, According to DelveInsight | Intercept Pharma, Enanta Pharma, COUR Pharma, Novartis, Gannex Pharma, Nanjing Chia-tai Tianqing - Barchart.com
Trade Recap: Why is Enanta Pharmaceuticals Inc stock going upQuarterly Profit Summary & Weekly Consistent Profit Watchlists - khodrobank.com
Using AI based signals to follow Enanta Pharmaceuticals Inc.Portfolio Performance Summary & Community Trade Idea Sharing - newser.com
Enanta Pharmaceuticals (NASDAQ:ENTA) Price Target Lowered to $12.00 at Evercore ISI - Defense World
H.C. Wainwright Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $20 - 富途牛牛
Evercore Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Cuts Target Price to $12 - 富途牛牛
Day Trade: Is AACTWS forming bullish engulfing patternsLong Setup & AI Enhanced Trading Signals - خودرو بانک
Aug Fed Impact: Is Enanta Pharmaceuticals Inc. stock a smart retirement pickJuly 2025 Summary & Detailed Earnings Play Alerts - خودرو بانک
Evercore ISI Group Lowers Price Target for Enanta Pharma (ENTA) | ENTA Stock News - GuruFocus
Enanta Pharmaceuticals Inc (ENTA) 財務データ
収益
当期純利益
現金流量
EPS
0.59%
0.59%
大文字化:
|
ボリューム (24 時間):